• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,488.96 1,073.61
( 1.42%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
65,182.04 1,842.97
(2.91%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Beryl Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524606
INE415H01017
18.6259045
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
10.05
EPS(TTM)
Face Value()
Div & Yield %
0.03
10
0
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales3.785.124.79
Other Operating Income0.070.040.04
Other Income 0.000.000.00
Total Income3.855.164.84
Total Expenditure 4.054.424.28
PBIDT-0.200.730.55
Interest 0.090.080.10
PBDT-0.290.650.45
Depreciation0.320.390.38
Tax-0.180.110.15
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.260.14-0.10
Reported Profit After Tax-0.170.010.02
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-0.170.010.02
EPS (Unit Curr.)-0.330.020.04
EPS (Adj) (Unit Curr.)-0.330.020.04
Calculated EPS (Unit Curr.)-0.330.020.04
Calculated EPS (Adj) (Unit Curr.)-0.330.020.04
Calculated EPS (Ann.) (Unit Curr.)-1.320.070.17
Calculated EPS (Adj) (Ann.) (Unit Curr.)-1.320.070.17
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity5.075.075.07
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-5.2914.2611.48
PBDTM(%)-7.6712.709.39
PATM(%)-4.500.200.42